Navigation Links
General Anxiety Disorder Global Clinical Trials Review, H2, 2013
Date:10/24/2013

London (PRWEB) October 24, 2013

General Anxiety Disorder Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “General Anxiety Disorder Global Clinical Trials Review, H2, 2013" provides data on the General Anxiety Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on General Anxiety Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating General Anxiety Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes /
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Surgeon General receives 2012 Distinguished Public Service Award from internal medicine physicians
2. Australian general practitioners in training spend less time with peds patients than with adults
3. General surgeons identify postoperative complications posing strongest readmission risk
4. Survival After General Anesthesia Vastly Improved: Study
5. Risk factors in hospital readmissions among general surgery patients identified in study
6. General thoracic surgeons emerge as leading providers of complex, noncardiac thoracic surgery
7. General Plastics to Showcase High-Strength, Lightweight Composite Core Foams at COMPOSITES 2013 January 29-31
8. Neuroinflammation may be behind general-anesthesia-associated learning disabilities
9. Customers Can Buy General Hearing Instruments' Hearing Aids Online
10. Sika Sarnafil Wins Excellence In Design Award For General Motors Project
11. Fibromyalgia prevalence at 2.1 percent of general German population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , ... June 30, 2015 , ... ... game’s most advanced protection at less thickness than any other padding in football. ... in impact protection and shock absorption, Gameday Armour is engineered with D3O protective ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up ... life. Back pain can range from a dull, constant ache (chronic) to a sudden ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain ...
(Date:6/30/2015)... ... , ... People who want to learn more about the ... experience (NDE) – and also want to understand why the military isn’t recognizing ... invited to visit https://zoom.us/webinar/register/f4a12556fe7c03f5dc2040ba88984b7b and RSVP their attendance at a special ...
(Date:6/30/2015)... ... ... When it comes to volunteering abroad, not many people end up doing ... high. However, there are affordable programs to be had such as those provided by ... such volunteer named Uzma Aishah, a student at the International Medical University in Malaysia, ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... AvePoint, ... the general availability of three new apps – AvePoint Watermark, AvePoint ... With the addition of these apps, workers can better streamline everyday business operations and ...
Breaking Medicine News(10 mins):Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4
... from Matigara, Darjeeling District in West Bengal & Kuttanad in ... H7) as per report received from High Animal Security Disease ... reported from these two places. ,In Matigara, ... death of 2500 birds on 5-6th May, 2007. A team ...
... in a support group after diagnosis, use of support ... survivors receive referrals to such programs from their physicians, ... finds that cancer survivors are more likely to attend ... conditions, but there is little active support for such ...
... A leading expert in Germany has spawned a major ... tonnes of methane into the atmosphere every year ... Keppler of the Max Planck Institute for Chemistry has ... January 2006 that they had detected methane exhaled from ...
... women with a history of migraine and other headaches are ... the eye which can lead to severe vision problems ... to a study published in the May 15, 2007, issue ... Neurology. ,For the study, researchers reviewed the headache ...
... conducted to understand dietary patterns and chronic obstructive pulmonary ... halves the chances of developing progressive inflammatory lung disease ... an umbrella term for chronic progressive lung disease, such ... tracked the health of almost 43,000 men, who were ...
... infant mortality, cancer, accidental death, and diabetes than any other ... to a state health official, the Sioux Falls Argus Leader ... Department, at the request of the Zaniya Task Force, recently ... the state's population and found what he called "very somber ...
Cached Medicine News:Health News:Psychosocial Support for Cancer Survivors Needs Strengthening 2Health News:Scientists Saying Against Trees Sparks Debate 2Health News:Mid-Life Headaches May Increase Risk of Vision Problems 2Health News:American Indians in South Dakota Have More Health Problems Than Others in State, Nationwide, Health Official Says 2
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... public offering of units. Each unit will consist of ... purchase common stock and Series B warrants to purchase ... offering would result in them beneficially owning more than ...
(Date:6/29/2015)... June 29, 2015  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... Officer and Chief Financial Officer, will present at the ... 2015 at 8:00 a.m. ET at Le Parker Meridien ... The presentation will be webcast live and will ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... a Standard of Care, WASHINGTON, March 17 ... the Society of Interventional,Radiology,s 33rd Annual Scientific Meeting show ... up a blood clot in most patients,much quicker than ... guided,directly to the clot via a catheter in the ...
... on Outcomes of New Analyses or Confirmatory Trial, ... Tuesday March 18, 2008, BERKELEY HEIGHTS, N.J., ... announced that the Food and Drug,Administration,s (FDA) Center ... available data are not adequate to support approval ...
Cached Medicine Technology:New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 2New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 3New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 4New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 2FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 3FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 4FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: